Editorial:: Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic 131I scanning

被引:34
作者
Wartofsky, L [1 ]
机构
[1] Washington Hosp Ctr, Dept Med, Washington, DC 20010 USA
关键词
D O I
10.1210/jc.87.4.1486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1486 / 1489
页数:4
相关论文
共 23 条
[1]   Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? [J].
Cailleux, AF ;
Baudin, E ;
Travagli, JP ;
Ricard, M ;
Schlumberger, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :175-178
[2]  
FATEMI S, 2001, 73 ANN M AM THYR ASS, P280
[3]   A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer [J].
Haugen, BR ;
Pacini, F ;
Reiners, C ;
Schlumberger, M ;
Ladenson, PW ;
Sherman, SI ;
Cooper, DS ;
Graham, KE ;
Braverman, LE ;
Skarulis, MC ;
Davies, TF ;
DeGroot, LJ ;
Mazzaferri, EL ;
Daniels, GH ;
Ross, DS ;
Luster, M ;
Samuels, MH ;
Becker, DV ;
Maxon, HR ;
Cavalieri, RR ;
Spencer, CA ;
McEllin, K ;
Weintraub, BD ;
Ridgway, EC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3877-3885
[4]  
Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO
[5]  
2-1
[6]   Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma [J].
Ladenson, PW ;
Braverman, LE ;
Mazzaferri, EL ;
BruckerDavis, F ;
Cooper, DS ;
Garber, JR ;
Wondisford, FE ;
Davies, TF ;
DeGroot, LJ ;
Daniels, GH ;
Ross, DS ;
Weintraub, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) :888-896
[7]  
Mazzaferri EL, 1999, ONCOLOGY-NY, V13, P391
[8]   Current approaches to primary therapy for papillary and follicular thyroid cancer [J].
Mazzaferri, EL ;
Kloos, RT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1447-1463
[9]   Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? [J].
Mazzaferri, EL ;
Kloos, RT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1490-1498
[10]   Using recombinant human TSH in the management of well-differentiated thyroid cancer: Current strategies and future directions [J].
Mazzaferri, EL ;
Kloos, RT .
THYROID, 2000, 10 (09) :767-778